Victoria Alonso, a prominent and long-serving executive at Marvel Studios who joined the firm before the release of the first Iron Man, has left the company, multiple sources said.
She left Marvel on Friday, according to reports. The reasons for the split are unclear. Alonso has been with the company from the beginning of the Marvel Cinematic Universe, logging an impressive 17 years with the company and witnessing its growth from a small operation running above a Beverly Hills Mercedes-Benz dealership to one that was eventually purchased by Disney.
The MCU rose to become the highest-grossing film franchise in history during her leadership. Alonso began working for the company in 2006 as the chief of visual effects and postproduction. In 2008, she co-produced Iron Man, which served as the first film in the Marvel Cinematic Universe. Moreover, she co-produced Captain America: The First Avenger (2011), Thor (2011), and Iron Man 2 (2010).
The Avengers (2012), a historic movie that made $1.5 billion worldwide and propelled Marvel to new heights, saw Alonso promoted to executive producer, demonstrating the viability of the shared cinematic universe idea.
Alonso worked on Marvel’s Disney+ TV series in addition to acting as executive producer on the studio’s future films. She received a promotion to the position of president, physical and postproduction, visual effects, and animation production in 2021.
She also produced Argentina, 1985, an international film that was nominated for an Oscar last year. Her departure coincides with Ant-Man and the Wasp: Quantumania’s underwhelming box office performance and poor reception from critics and fans.
Alonso has been a crucial spokesperson for the studio’s representation efforts in addition to her work behind the scenes. She was very vocal during Disney’s legal battle with Florida over the state’s “Don’t Say Gay” bill. “As long as I am at Marvel Studios, I will fight for representation,” Alonso, who is gay, said at the time.
Also Read: Amul To Expand Selection Of Non-Dairy Products: MD Jayen Mehta
